NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CTO Realty Growth, Inc. ("CTO" or "the Company") (NYSE:CTO). Investors who purchased CTO securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: […]

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PACS Group, Inc. ("PACS Group" or "the Company") (NYSE:PACS). Investors who purchased PACS Group securities prior to April 11, 2024, and continue to hold to the present, are encouraged

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Apple Inc. ("Apple" or "the Company") (NASDAQ:AAPL). Investors who purchased Apple securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/AAPL. Investigation Details

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innodata Inc. ("Innodata" or "the Company") (NASDAQ:INOD). Investors who purchased Innodata securities prior to May 9, 2019, and continue to hold to the present, are encouraged to obtain additional

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Atkore Inc. ("Atkore" or "the Company") (NYSE:ATKR). Investors who purchased Atkore securities prior to August 2, 2022, and continue to hold to the present, are encouraged to obtain additional information

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lifecore Biomedical, Inc. ("Lifecore" or "the Company") (NASDAQ: LFCR). Investors who purchased Lifecore securities prior to October 7, 2020, and continue to hold to the present, are encouraged to

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE:NVO). Investors who purchased Novo Nordisk securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Petco Health and Wellness Company, Inc. ("Petco" or "the Company") (NASDAQ:WOOF). Investors who purchased Petco securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Acadia Healthcare Company, Inc. ("Acadia Healthcare" or "the Company") (NASDAQ:ACHC). Investors who purchased Acadia Healthcare securities prior to February 28, 2020, and continue to hold to the present, are

NEW YORK CITY, NY / ACCESS Newswire / July 1, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EchoStar Corporation ("EchoStar" or "the Company") (NASDAQ:SATS). Investors who purchased EchoStar securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/SATS. Investigation